Next Article in Journal
Exploring Large MAF Transcription Factors: Functions, Pathology, and Mouse Models with Point Mutations
Previous Article in Journal
Integrated Multi-Tissue Transcriptome Profiling Characterizes the Genetic Basis and Biomarkers Affecting Reproduction in Sheep (Ovis aries)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Factors Influencing the Maturation and Developmental Competence of Yak (Bos grunniens) Oocytes In Vitro

1
College of Animal and Veterinary Sciences, Southwest Minzu University, Chengdu 610041, China
2
Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization Key Laboratory of Sichuan Province, Chengdu 610041, China
3
Key Laboratory of Animal Science of National Ethnic Affairs Commission of China, Southwest Minzu University, Chengdu 610041, China
*
Author to whom correspondence should be addressed.
Genes 2023, 14(10), 1882; https://doi.org/10.3390/genes14101882
Submission received: 14 August 2023 / Revised: 17 September 2023 / Accepted: 25 September 2023 / Published: 27 September 2023
(This article belongs to the Section Animal Genetics and Genomics)

Abstract

:
The yak (Bos grunniens) is a unique breed living on the Qinghai–Tibet Plateau and its surrounding areas, providing locals with a variety of vital means of living and production. However, the yak has poor sexual maturity and low fertility. High-quality mature oocytes are the basis of animal breeding technology. Recently, in vitro culturing of oocytes and embryo engineering technology have been applied to yak breeding. However, compared to those observed in vivo, the maturation rate and developmental capacity of in vitro oocytes are still low, which severely limits the application of in vitro fertilization and embryo production in yaks. This review summarizes the endogenous and exogenous factors affecting the in vitro maturation (IVM) and developmental ability of yak oocytes reported in recent years and provides a theoretical basis for obtaining high-quality oocytes for in vitro fertilization and embryo production in yaks.

1. Introduction

The yak is a unique breed that lives in the Qinghai–Tibet Plateau and offers various necessities for local people’s survival and production. However, the reproductive performance of the yak is low. Yaks are generally calved every other year, with one in two years or two in three years, and the average annual reproductive rate for female yaks is less than 60% [1,2]. The yak has low reproductive performance due to various factors, including seasonal breeding, delayed puberty, and a low frequency of estrus [2,3,4,5].
In order to improve the reproductive performance of yaks, assisted reproductive procedures such as in vitro fertilization (IVF), somatic cell nuclear transfer (SCNT), and embryo transfer (ET) have been widely used in yak breeding [6,7,8,9]. These technologies cannot be implemented without high-quality mature oocytes. The process of oogenesis can be divided into three main stages: The first stage is the proliferation stage. This stage begins with the migration of primordial germ cells to the embryonic reproductive ridge that has not yet begun to differentiate. At this time, the female germ cells are called oogonia, and the oogonia carry out mitosis and proliferate continuously. In the middle and late stages of embryonic development, some oogonia begin to accumulate nutrients, grow, and undergo the first meiosis (MI). These cells are called primary oocytes. Primary oocytes go through the leptotene, zygotene, and pachytene stages, and finally arrest in the diplotene stage. The second stage is the growth stage, in which the volume of oocytes increases significantly, the number and shape of organelles changes greatly, and many nutrients, such as protein, carbohydrates, and lipid droplets are accumulated in the cytoplasm. The third stage is the maturity stage [10]. The oocyte completes its growth and approaches the size of the mature oocyte in volume. At this time, the arrested oocyte has an intact nuclear envelope known as the germinal vesicle (GV). Upon sexual maturity, primary oocytes resume meiosis by overcoming the effect of oocyte maturation inhibitors secreted by granulosa cells under the influence of luteinizing hormone (LH) peaks. After that, a series of changes, such as germinal vesicle break down (GVBD), chromosome aggregation, and uniform distribution of organelles in the cytoplasm occurs, and the primary oocyte subsequently completes the first meiosis, produces a secondary oocyte with half the number of chromosomes, and extrudes a first polar body. Then, the oocyte arrests again in the second meiotic metaphase (MII) and waits for fertilization. Sperm penetration causes the second polar body to extrude and the formation of a diploid fertilized egg, initiating the development of the fertilized egg, cleavage, and blastocyst formation [11,12,13].
A series of drastic morphological and molecular changes occur during oocyte maturation, such as the change in transcription, the repositioning of organelles, and the storage and utilization of maternal materials. Therefore, oocyte maturation is a complex process influenced by several internal and external influences [14,15,16]. Despite researchers continuously trying to improve the culture system of mature oocytes, the maturity rate of oocytes in vitro remains lower than that in vivo [17,18]. The low effectiveness of oocyte maturation in vitro and poor embryo quality seriously restrict the utilization of in vitro fertilization and embryo production in the yak. This review summarizes numerous recently reported internal and external factors affecting yak oocytes’ maturation and developmental competence in vitro, providing a theoretical basis for obtaining high-quality oocytes for fertilization and embryo production.

2. Samples

2.1. The Development Stage of Oocytes

Oocyte quality and maturation rate vary depending on follicle type and morphology. Liu Ben et al. found no noticeable difference in the cleavage rates of embryos after fertilization between oocytes from pre-estrus calves and adult yaks. However, the blastocyst rate of fertilized embryos from pre-estrus calves was lower than that those from adult yaks [19]. Yan Ping et al. discovered that the in vitro maturation rate of follicular phase oocytes was significantly higher than that of luteal phase oocytes [20]. The maturation and cleavage rates of ovarian surface oocytes were significantly higher than those of ovarian oocytes [21]. Li Tianqiang et al. compared different types of follicles and discovered that the number of available cumulus–oocyte complexes (COCs) and the maturity rate of oocytes obtained from medium follicles were higher than those of small, large, and engorged follicles [22].

2.2. The Layers of COCs

According to the criteria established by Wang Yuheng et al. for the yak oocyte classification, yak COCs were divided into four grades [23]. The results of the four types of COC culture revealed that the oocyte maturation rate was higher in grade A and B COCs [23]. Sun Yonggang et al. also graded COCs and cultured them according to the above standard. The results showed that grade A COCs had the highest maturity, cleavage, and blastocyst rates. This indicated that the number of layers of cumulus cells had an important influence on oocyte maturation and the degree of embryo development in vitro [6].

3. Endogenous Factor

3.1. Dynamic Transcripts and Protein Changes

The maturation and development of oocytes are complicated processes involving the regulation of various genes and proteins [15,24]. Dynamic changes of transcripts and proteins were observed during the development and maturation of yak oocytes [25,26]. Pei Jie et al. constructed the molecular structure of yak ovarian cortex cells using single-cell RNA sequencing (scRNA-seq). They identified the molecular features and biological functions of different cell populations. Differentially expressed genes (DEG) between oocytes and other types of ovarian cells were mainly enriched in cell cycle transition, DNA repair, and chromosome segregation processes, according to Gene Ontology (GO) enrichment analysis. Gene expression specificity testing indicated that the characterized genes CENPF, TOP2A, MIS18BP1, FST, and INHA were highly expressed in yak oocytes. The FST and TOP2A genes could be considered as the molecular features of yak oocytes within primordial follicles. They also discovered that the yak oocytes regulated the other types of ovarian cells primarily via the interaction between the ligands FAM3, INHA, and JAG1 with their corresponding receptors. However, the endothelial, epithelial, and granulosa cells regulated the oocytes principally via the BMP family [27].
Lan Daoliang et al. sequenced the transcriptome of MII stage yak oocytes and analyzed the primary biological functions and signaling pathways involved in the differentially expressed genes. KEGG analysis revealed that actin cytoskeleton regulation was the most significantly enriched pathway. the cell cycle, tight junction, adhesion patch, MAPK signaling, Wnt signaling, and endocytosis pathways were effectively enriched. The results suggested that yak oocyte maturation involved a series of dynamic processes that was highly spatially and temporally regulated [28]. Moreover, they comparatively analyzed the transcriptome data of yak oocytes matured in vitro at the MII and GV stages. They screened 4767 DEGs, of which 1418 were up-regulated and 3349 were down-regulated. Apoptotic, endocytosis, and metabolic pathways were the primary key regulatory pathways related to the up-regulated genes, while metabolic, pyruvate metabolism, focal adhesion, and oxidative phosphorylation were the key regulatory pathways related to down-regulated genes. Additionally, they discovered that immune-related interleukin family and interferon family genes were significantly differently expressed during the IVM of yak oocytes [29].
Zhao Yanling et al. applied the liquid chromatography tandem mass spectrometry (LC-MS-MS) technique to construct the protein expression profiles of yak oocytes at the GV stage. They identified 550 proteins, of which MVP, PDIA3, HSP90B1, HSPA5, and BSA were the proteins with the highest abundance expression in yak oocytes. GO analysis revealed that the proteins related to cell components were mainly concentrated in the cytoplasm (125 proteins). In the enrichment analysis related to molecular function, the number of proteins that perform the function of poly A binding RNA was the highest (54 proteins), In enrichment analyses related to biological processes, the number of proteins involved in the negative regulatory process of endopeptidase activity was the highest (26 proteins). According to KEGG analysis, the representative pathways include the complement system, ribosome metabolism, phosphatidylinositol 3 kinase-serine/threonine kinase (PI3K-Akt) signaling, and carbon metabolism pathways. Additionally, protein network analysis revealed that ALB, GAPDH, HSP90AB1, ACLY, ACTA1, HSPA8, ACTG1, UBA52, PLG, and EEF2 were the key nodes of protein–protein interactions (PPI) in oocytes [30]. Huang Yong applied isobaric tags for relative and absolute quantitation (iTRAQ) and high-performance liquid chromatography–electrospray tandem mass spectrometry (LC-ESI-MS-MS) techniques to characterize the proteins of yak GV and MII oocytes, identifying 1188 proteins. GO and KEGG analyses showed that these proteins were involved in 263 signaling pathways. Among these pathways, the metabolic pathway was the most significantly enriched. Furthermore, the research discovered that these proteins were mainly involved in protein post-translational modification, conversion, molecular chaperoning, and other general functions. Moreover, this research identified 161 differentially expressed proteins between two stages, with 81 being up-regulated and 80 being down-regulated. These differentially expressed proteins were also most significantly enriched in the metabolic pathway, followed by the actin cytoskeleton pathway [31].

3.2. Epigenetic Regulations

Epigenetic regulation is a kind of regulation of gene expression by changing non-gene sequence, mainly including DNA methylation, histone modification (acetylation, methylation, phosphorylation, etc.), and regulation of non-coding RNA, etc., which is a hot research topic in different fields of biology [32,33]. The recent progress in the study of epigenetic regulations on the maturation and developmental competence of yak oocytes in vitro is as follows:

3.2.1. DNA Methylation

During mammalian development, DNA methylation plays a crucial role in genomic imprinting, transposon silencing, X-chromosome inactivation, and tissue-specific gene expression regulation [34]. Li Qin found that Aflatoxin B1 (AFB1) exposure caused early apoptosis in yak oocytes and affected the DNA methylation levels of mature oocytes. These effects were specifically demonstrated by the fact that AFB1 exposure significantly enhanced the fluorescence signal of DNA methylation, enhanced the mRNA transcript abundance of the methylation transferase DNMT1, and decreased the mRNA transcript abundance of DNMT3a and DNMT3b. It is well known that the major function of the methyltransferases DNMT3a and DNMT3b is to establish DNA methylation, and the methyltransferases DNMT1 play a major role in the subsequent maintenance of genome-wide methylation patterns [35,36,37]. These results suggested that AFB1 exposure was detrimental to the establishment and maintenance of DNA methylation during yak oocyte maturation. In contrast, the addition of 50 µg/mL AA during the IVM of yak oocytes attenuated these impairments, restored the mRNA transcript abundance of DNMT1 and DNMT3a, and attenuated the DNA methylation [38].
In addition, adding 50 µg/mL AA increased the mRNA transcript abundance of DNMT3a and ten-eleven translocation enzyme (TET3) at the 2-cell, 4-cell, 8-cell, and morula stages of yak embryos. At the blastocyst stage, the promoter region of pluripotency gene NANOG exhibited moderate methylation. Addition of 50 µg/mL AA decreased the methylation level of the NANOG promoter, and significantly increased the mRNA transcript abundance of NANOG. These results suggested that 50 µg/mL AA might regulate the formation of yak blastocysts via regulating the methylation and expression of NANOG [38,39].

3.2.2. Histone Modification

Histone modification refers to altering the interaction of histones with DNA by adding or removing specific chemical markers on histones, thereby affecting the gene transcription regulation and the occurrence of other cellular processes [40,41]. Several histone modifications, including methylation, acetylation, ubiquitination, and phosphorylation, are essential for oocyte maturation [42,43,44,45].
KDM1A is a histone demethylase with specificity for H3K4me2/me1 demethylation [46]. Han Jie et al. discovered that the KDM1A mRNA expression decreased and then increased during IVM of yak oocytes, with the MI stage exhibiting the lowest KDM1A expression. After repressing the expression of KDM1A in yak oocytes by adding GSK-KDM1A, the specific inhibitor of KDM1A, the cumulus cell expansion, the first polar body excretion rate, and the cleavage rate of yak oocytes were significantly decreased. The expressions of OCT4 and SOX2 were significantly up-regulated after the treatment. The results suggested that KDM1A was involved in regulating the meiosis of yak oocytes, possibly influencing oocyte maturation and embryo development [47,48].
KDM2 is a demethylase with a JmjC domain [49]. Cai Wenyi investigated the function of KDM2A and KDM2B in yak oocytes and discovered that KDM2 was dynamically expressed during oocyte meiosis. Its mRNA/protein expression level was significantly higher in the MI stage than in the GV and MII stages. Moreover, adding butyrazide, a specific inhibitor of KDM2, to the in vitro maturation medium reduced oocyte maturation but increased the cleavage and blastocyst rates, suggesting that KDM2 may play opposing roles in regulating oocyte maturation and embryo development in yaks [50].
SIRT1 is a class-III nicotine adenine dinucleotide (NAD)-dependent histone deacetylases (HDACs) that have been proven to be essential for delaying oocyte aging and promoting oocyte maturation in mice [51,52]. Xiong Xianrong et al. presented that SIRT1 was involved in the IVM of yak oocytes by adding the specific agonist SRT2104 and the inhibitor inauhzin of SIRT1 to the in vitro medium of yak COCs. The results disclosed that adding SRT2104 to oocytes alleviated aging and improved the rate of IVM and the developmental ability of early embryos. In contrast to the inauhzin treatment group, SRT2104 addition significantly increased the degree of cumulus cell expansion and the cleavage and blastocyst rates of IVF embryos. It significantly inhibited the reactive oxygen species (ROS) level in oocytes by up-regulating SIRT1, FOXO3a, and SOD2 mRNA expressions and down-regulating BAX mRNA expression [53].

3.2.3. miRNA

miRNAs are a class of small non-coding RNAs that play a regulatory role at the post-transcriptional level by recognizing binding sites in the untranslated regions of target genes, leading to mRNA degradation or protein translation inhibition [54,55]. Recently, miRNAs have played important roles in mammalian oocyte maturation, follicular development, and early embryonic development [56,57,58].
Xiong Xianrong et al. sequenced miRNAs in yak GV and MII stage oocytes and obtained 801 and 1018 known miRNAs, respectively. Seventy-five of these miRNAs were significantly differentially expressed, with 47 miRNAs exhibiting up-regulated expression and 28 miRNAs exhibiting down-regulated expression in MII stage oocytes compared to the GV stage. Moreover, they analyzed the expression patterns of miR-16 and miR-342 in GV and MII oocytes and preimplantation embryos (two-cell, four-to-eight-cell, and blastocyst). The results revealed that miR-16 was highly expressed in GV oocytes but significantly decreased from the MII stage to the blastocyst stage. However, miR-342 expression was significantly higher in MII oocytes than in GV oocytes and significantly decreased from the two-cell embryo to the blastocyst stage. Subsequently, the miR-16 and miR-342 potential target gene expressions, such as BCL2, CCND1, DNMT1, and BMP7 were analyzed in GV oocytes, MII oocytes, and preimplantation embryos. The results showed that BCL2, CCND1, and BMP7 were expressed in the opposite direction to miR-16 and miR-342, while DNMT1 had no defined expression pattern throughout the developmental stages [59].
Xiong Xianrong et al. studied the role of miR-342-3p in the meiotic maturation of yak oocytes. They discovered that miR-342-3p inhibitor effectively up-regulated DNMT1 expression and significantly inhibited oocyte meiotic maturation by targeting the 3′-untranslated regions (UTR) of DNMT1 [60]

3.3. G Protein-Coupled Receptor 50 (GPR50)

GPR50 is an orphan G protein-coupled receptor on the X chromosome [61]. Previous research revealed that GPR50 was strongly expressed in yak brain, ovary, and testis tissues, implying that GPR50 might have a function in reproductive development [62]. Yao Ying et al. found that the GPR50 protein was centrally expressed in the membrane during the germinal vesicle (GV) phase of yak oocytes, with the highest GPR50 expression level during the MII phase [62]. Based on these observations, researchers investigated the impacts of GPR50 knockdown and overexpression on yak oocytes. The results indicated that the GPR50 knockdown significantly reduced the oocyte maturation rate and the polarbody excretion rate, while GPR50 overexpression exerted no significant influence on the excretion rate and maturity level of the yak oocytes, suggesting that GPR50 might play a crucial role in yak oocyte maturation in vitro [63].
The effects of some endogenous factors on yak oocytes and the possible mechanisms are shown in Table 1.

4. Exogenous Factor

4.1. Growth Factor

Growth factors are a class of peptides that regulate multiple effects, such as cell growth and other cellular functions, by binding to specific, high-affinity cell membrane receptors. They play critical roles in resuming oocyte meiosis, oocyte maturation, and follicular development [64,65]. Moreover, growth factors can significantly improve the development ability of embryos and promote blastocyst formation, which has great biological effects on the development processes and different developmental periods of mammalian embryos [66,67,68].
Several important growth factors, such as epidermal growth factor (EGF), insulin-like growth factor I (IGF-1), fibroblast growth factor 10 (FGF10), and leukemia inhibitory factor (LIF) are essential for oocyte maturation and embryo development. EGF can promote cell proliferation, differentiation, and mammalian oocyte maturation [64,69,70,71]. Ma Li et al. discovered that supplementation with 40 μg/mL EGF could significantly improve oocyte maturation and the development ability of parthenogenetic embryos [72]. Pan Yangyang, et al. found that the medium supplemented with 100 ng/mL EGF could significantly increase the yak COC maturation rate, and cleavage and blastocyst rates after fertilization. This might be caused by the inhibition of EGF on the expression of the pro-apoptosis gene BAX and the promotion of EGF on the expression of anti-apoptosis genes BI-1 [73].
IGF-1 belongs to the insulin-like growth factor family [74], which is involved in mediating cellular proliferation, differentiation, and apoptosis, and plays a critical role in mammals’ growth and development [75]. Pan Yangyang et al. discovered that adding 100 ng/mL IGF-1 to the culture medium significantly increased the yak oocyte maturation rate in vitro and the cleavage and blastocyst rates of chemically activated embryos. Further study proved that this result was due to the up-regulation of IGF-1-induced cold-inducible RNA-binding protein (CIRP) [76].
FGF10 is a paracrine fibroblast growth factor involved in numerous biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion [77,78,79,80]. It is also involved in follicle development and oocyte maturation in various mammals [81,82]. Pan Yangyang et al. found that adding 5 ng/mL of FGF10 to the culture medium of yak COCs improved the yak oocyte maturation rate and fertilization ability. This positive effect was achieved via the up-regulation of FGF10 on CD9, CD81, DNMT1 and DNMT3B expressions in COCs to optimize sperm–egg interaction and DNA methylation during fertilization [6].
LIF is a potent cytokine in the IL-6 family of cytokines [83]. Zhao Tian et al. indicated that adding LIF during the IVM of yak oocytes improved oocyte quality, maturation competence, blastocyst quality, and oocyte development. The addition of LIF (50 ng/mL) to the maturation medium could increase the maturation rate and significantly lower ROS generation and the apoptosis levels of oocytes by increasing the mRNA transcription levels of anti-apoptotic and antioxidant-related genes BCL2, CAPASE3, SURVIVIN, SOD2 and GPX4 in yak oocytes. Furthermore, blastocysts formed from 50 ng/mL LIF-treated oocytes had higher total cell numbers and lower apoptosis rates than the control group [84].

4.2. Antioxidants

ROS are small molecules produced by biological aerobic metabolism, an include superoxide, peroxide, and oxygen radicals [85]. Reactive oxygen molecules are chemically reactive due to extra-nuclear unpaired electrons. Excessive ROS attack intracellular small molecules, such as lipids, proteins, and nucleic acids, leading to DNA degradation in the nucleus and mitochondria, causing intracellular protein denaturation, inactivating some important enzymes, inducing cellular plasma peroxidation, and ultimately triggering cell apoptosis [86]. High ROS levels accelerated the oocyte senescence, reduced oocyte quality, and caused oocyte apoptosis [87,88].
Vitamin A is an indispensable nutrient that regulates physiological processes such as reproduction, embryonic development, vision, growth, cell differentiation, and proliferation [89]. Vitamin A can be oxidized to retinoic acid (RA) via oxidation reactions, and RA functions as a gene expression regulator [90]. Vitamin A regulates oocyte maturation via typical and atypical signaling pathways [91,92]. According to studies, adding 2 μM Vitamin A to yak oocytes in vitro maturation medium significantly increased the rate of IVM and parthenogenetic activation (PA) embryo cleavage rate. The expressions of STRA8, RARA, and RXRA were highest in the MII stage compared with those in the GV and MI stages under the treatment of 2 μM Vitamin A. Additionally, the mRNA expressions of several genes in the typical signaling pathway, including RXRA, RARA, and STRA8, were significantly higher than those of MEK and MEK1, which were node genes of the atypical signaling pathway. These results suggested that RA was mainly dependent on the typical signaling pathway for the yak oocyte development in vitro [93,94].
Vitamin C (ascorbic acid) is a strong water-soluble antioxidant that can catalyze the reduction of oxidized glutathione to reduced glutathione [95]. Exposure of yak oocytes to 1 nM Aflatoxin B1 (AFB1) induced early oocyte apoptosis and increased intracellular ROS levels. It caused incomplete actin and uneven distribution of mitochondria, resulting in decreased quality of mature yak oocytes. However, adding 50 μg/mL Vitamin C to the culture medium protected yak oocytes from the toxic effects of AFB1 exposure. Specifically, 50 μg/mL Vitamin C reduced intra-oocyte ROS levels, repressed early oocyte apoptosis, improved mitochondrial distribution status, and restored actin distribution [38,96].
The addition of antioxidants to oocytes and embryos during in vitro culture is necessary to maintain normal levels of intracellular ROS. Melatonin is a natural endogenous indole hormone produced by the mammalian pineal gland [97]. Since melatonin is fat- and water-soluble, it can easily transfer hydrogen and electrons across cell membranes, directly scavenging free radicals and reducing cellular ROS levels [86]. Peng Wei et al. investigated the effects of melatonin on the IVM of yak oocytes by adding different concentrations of melatonin to the culture medium of yak COCs. They discovered that adding 10−9 M melatonin could significantly increase the oocyte maturation rate, IVF embryo cleavage and blastocysts rates, and GSH content of oocytes and blastocysts. Reductions of ROS levels, mitochondrial protein extent, DNA damage, and cell apoptosis were observed after melatonin treatment. Additionally, 10−9 M melatonin repaired the spindle mismatch and chromosomal abnormalities caused by oxidative stress. The results suggested that 10−9 M melatonin addition could alleviate oxidative stress during the IVM of oocytes and improve the oocyte maturation rate and the developmental ability of subsequent embryos [98,99].
Li Ruizhe compared the effects of antioxidants, including melatonin, Vitamin C, resveratrol, and cysteamine, on the maturation and developmental capacity of yak oocytes in vitro. The results showed that adding melatonin to the oocyte maturation solution significantly increased the maturation rate and the proportion of mitochondrial homogenous distribution of yak oocytes. The oocyte cleavage rate of in-vitro-fertilized embryos also increased. Among these three antioxidants, cysteamine had the strongest effect on the increase of GSH content in oocytes [100].

4.3. Microelement

Zinc (Zn) is an essential trace element in mammals that plays an important role in cell growth, proliferation, division, and immunity [101,102]. Xiong Xianrong et al. discovered that adding 2 mg/L zinc sulfate to the IVM medium of yak oocytes increased glutathione (GSH) content, superoxide dismutase (SOD) activity, and the blastocyst rate, and significantly reduced ROS levels. This effect could be achieved by Zn2+ inducing the up-regulation of Zn transporters 3 (ZnT3), Zrt, and Irt-like protein 14 (ZiP14) expressions in yak oocytes [103]. Hu Jiajia et al. obtained similar results in their study. Moreover, they discovered that adding 2 mg/L zinc sulfate significantly increased the expression levels of Solute-linked carrier (SLC30A) and SLC39A family members, including SCL30A3, SLC30A6, SCL30A9, SLC39A6 and SLC39A14 in yak mature oocytes, facilitating the cleavage of the fertilized ovum and blastocyst formation [104]. Feng Yun et al. revealed that adding 0.8 mg/L zinc sulfate could improve the yak oocyte maturation and the efficiency of in vitro fertilization by increasing the antioxidant enzyme gene (SOD1, CAT, TXN1, and PRD1) expression levels, and also up-regulating the cumulus cell expansion related genes (PTX3 and TSG6) in the oocyte [105].
Calcium (Ca) is an important second messenger in cells, and the changes in Ca2+ concentration are closely related to regulating physiological functions by affecting signal transduction [106]. Chen demonstrated that adding Ca2+ at 0.24 mM in yak oocyte culture medium significantly increased the oocyte maturation rate in vitro. The mechanism was that Ca2+ activated the activity of calmodulin-dependent protein kinaseII (CaMKII), increased GSH content, and decreased the ROS level in the oocyte. Ca2+ up-regulated the expressions of BCL-2, EGF, EGFR, and C-FOS, whereas it down-regulated BAX expression [107].
Selenium (Se) is an essential trace element for reproduction, immunity, antioxidant systems, embryonic growth, and other physiological functions [108,109,110]. Xiong Xianrong et al. observed that 2 μg/mL of sodium selenite significantly increased the glutathione peroxidase (GSH-Px) activity in the oocytes and the blastocyst rate of subsequent embryos by adding sodium selenite to the in vitro culture medium of yak COCs. Those effects were achieved by increasing the selenoprotein synthesis-related gene expression levels, including GPX4, SEPP1, RPL22, and CCND1 in oocytes and cumulus cells [111].

4.4. Small Molecule Compounds

Cyclic adenosine monophosphate (cAMP) is the first discovered second messenger. cAMP can regulate the various target genes’ transcription, primarily via protein kinase A (PKA) and its downstream effectors [112]. cAMP plays a key role in maintaining oocyte meiotic arrest and initiating meiotic resumption in mammalian oocytes [113,114]. Previous studies have demonstrated that maintaining cAMP levels in oocytes before oocyte maturation could temporarily repress spontaneous meiotic resumption, thereby improving oocyte developmental competence and subsequent embryonic development [115,116,117,118]. Xiong Xianrong et al. revealed that a supplement with a cAMP activator, cilostazol, would benefit yak oocytes IVM by increasing cAMP and GSH levels and modulating mRNA expression patterns during pre-IVM. Specifically, adding cilostazol to the in vitro maturation medium and pre-IVM for 2 h or 4 h significantly increased the PKA1 and CY3 mRNA expression levels. It also significantly decreased the PDE3A mRNA expression level in yak COCs and blastocysts [119].
Roscovitine and C-type natriuretic peptide (CNP) are two meiotic arrest factors promoting yak oocyte maturation in vitro. Roscovitine is a member of the 2,6,9-trisubstituted purine family and has a structure similar to ATP. Therefore, roscovitine interacts with amino acids in the ATP-binding pocket of the catalytic domain of some Cyclin-dependent kinases (CDK), preventing ATP from binding to CDK, inhibiting CDK activity, and ultimately blocking the cell cycle [120]. Pretreatment of yak COCs with 12.5 μM roscovitine for 6 h followed by conventional IVM improved the quality of yak mature oocytes. Liu Yu counted the cell expansion index (CEI) of ovarian thalamus granulosa cells after treating pre-IVM yak COCs with different concentrations of roscovitine. They discovered that pretreatment with 12.5 μM roscovitine for 6 h significantly increased the CEI of COCs. This treatment significantly reduced the ROS content in oocytes, promoted the uniform distribution of mitochondria, and enhanced the structure of transzonal projections (TZPs), thereby improving the quality of yak oocytes. Furthermore, this treatment significantly up-regulated the mRNA expressions of antioxidant gene SOD2, anti-apoptotic gene BCL-2, and development-related genes GDF9, EGFR, and ZAR1, and significantly down-regulated the mRNA expression of the pro-apoptotic gene BAX [121].
CNP is a natural determinant of meiotic arrest that can maintain gap junction activity and support the key gene expressions essential for oocyte development [122]. Jing Tian counted the number of yak GV oocytes cultured with different concentrations of CNP and discovered that the quality, maturation rate, and blastocyst rate of yak oocytes could be significantly improved by pre-IVM of oocytes at 100 nM CNP for 6 h and IVM for 28 h. This treatment significantly increased TZP and GSH protein expressions and decreased ROS levels in yak oocytes. These effects might be due to CNP significantly promoting the expressions of CNP receptor gene NPR2, anti-apoptotic gene BCL-2, and growth differentiation factor GDF9 in oocytes and blastocysts. CNP suppressed the EGF and its receptor EGFR gene expressions in oocytes while promoting EGF, EGFR, and DNMT1 expressions in blastocysts and repressing the expression of pro-apoptotic gene BAX in blastocysts [123].
Current studies on mouse, pig, and buffalo oocytes indicate that glucose is an important energy source for oocyte maturation [124,125,126,127]. Sucrose plays an important role in oocyte development, restoration of oocyte aging, and oocyte cryopreservation [128,129,130]. Shi Xian et al. discovered that an in vitro maturation medium containing 10 mmol/L glucose could significantly increase the nucleus maturation rate of yak oocytes and the cleavage rate of in vitro fertilization embryos. They also indicated that a medium containing 10 mmol/L sucrose could significantly increase the nucleus maturation rate of yak oocytes [131].

4.5. Hormones

Xiao Xiao et al. demonstrated that supplementing IVM medium with 5 μg/mL FSH and 50 IU/mL LH improved the developmental ability of yak oocytes after in vitro fertilization (IVF) [132]. He Honghong et al. studied the effects of different concentrations of FSH concentrations on yak oocytes and revealed that the oocyte maturation rate was highest in the 5 μg/mL FSH treatment group. Further study indicated that FSH might improve yak oocyte development by increasing EGF and EGFR mRNA expression levels, and it might inhibit oocyte apoptosis by increasing antiapoptotic gene BCL-2 expression while reducing pro-apoptotic gene BAX expression [133].
Estradiol (E2) is the most active and predominant maternal estrogen during pregnancy [134]. A supplement of exogenous E2 or promoting endogenous E2 synthesis and secretion can improve oocyte maturation and increase cumulus cell spread during oocyte maturation in various animals [135,136,137,138,139]. Pan Yangyang et al. discovered that adding 10−4 mM endogenous 17β-estradiol to the IVM medium of COCs could increase the cumulus expansion and subsequent oocyte development. These might result from increasing the expressions of cumulus-expansion-related factors (HAS2, PTGS2, and PTX3) and the oocyte-secreted factors (GDF9, FGF10, and BMP15) [140].
Rfamide-related peptides 3 (RFRP-3), a structural and functional homolog of gonadotropin-inhibiting hormone (GnIH), has been proposed as a new breeding inhibitory neurohormonal peptide that plays a crucial role in the reproductive axis across various species [141,142]. Xiong Xianrong et al. showed that RFRP-3 might inhibit yak oocyte maturation and developmental potential by binding with its receptor GPR147. Specifically, high-dose (10−6 mol/L) RFRP-3 inhibited yak oocyte proliferation, induced oocyte apoptosis, and decreased 17β-estradiol and progesterone (P4) concentrations. RFRP-3 dose-dependently elevated the expression of apoptosis markers (Caspase and Bax), whereas the expression levels of steroidogenesis-related factors (LHR, StAR, 3b-HSD) were down-regulated in a dose-dependent manner [143].
Cytochrome P450arom (CYP19A1) is the key enzyme for gonadal hormone synthesis in most animals [144]. CYP19A1 up-regulated the endogenous E2 level and enhanced the developmental ability of yak oocytes. Specifically, the treatment of CYP19A1 activator AFB1 up-regulated the endogenous E2 level and increased the rates of IVM and blastocysts, while decreasing the E2 level. IVM and blastocyst rates were observed in the CYP19A1 inhibitor BPA treatment group, which implied that CYP19A1 played an essential role in oocyte and embryo development of yaks [145].

4.6. Platelet-Activating Factor (PAF)

PAF is an acetylated glycerol signaling phospholipid important physiological regulator in reproduction [146]. PAF exerts its actions via activating specific PAF receptors (PAF-R) in cells and tissues of the female reproductive tract [147]. Wang Qin explored the role of PAF in the maturation of yak oocytes and early embryonic development by adding different concentrations of PAF to the maturation medium of COCs in vitro. The results showed that 10−7 mol/L PFA significantly increased the maturation, cleavage, and blastocyst rates of yak oocytes by regulating BAX, BCL-2, EGF, EGFR, C-FOS, OCT-4, and NANOG gene expressions [148,149].
The effects of some exogenous factors on yak oocytes and the possible mechanisms are shown in Table 2.

5. Environment Factor

5.1. Temperature

Pang Bo et al. investigated the effects of ovarian preservation temperature and the culture methods on the maturation rate of yak oocytes in vitro, and the results showed that preserving the ovaries from 20 °C to 25 °C could improve the oocyte maturation rate in vitro [150]. Ma Li et al. preserved fresh yak ovaries in saline at different temperatures (15–20 °C; 25–30 °C; 35–40 °C). The results indicated that 25–30 °C was the optimal temperature for the ovarian transport of yaks. The maturation rate of oocytes, eight-cell embryo formation, and blastocyst rates of IVM and parthenogenetic activation (PA) embryos were significantly higher than those of other groups within this temperature range [151].

5.2. Oxygen

Oxygen (O2) is vital to maintain and complete oocyte maturation and embryonic development. Changes in oxygen concentration during oocyte maturation in vitro affect nuclear DNA methylation, intracellular reactive oxygen species (ROS) levels, and cellular aging [87,152]. Low oxygen levels are the naturally preferred microenvironment for most processes during early development and mainly drive proliferation [153,154]. Several studies proved that culturing oocytes and embryos under low oxygen conditions improved their developmental capacity [155,156,157].
He Honghong et al. investigated the development of yak oocytes and preimplantation embryos under low oxygen concentrations. The results showed that 5% oxygen facilitated yak oocyte maturation in vitro and significantly increased the cleavage and blastocyst rates of the subsequent PA embryos. The blastocyst rate of IVM embryos was significantly increased at the same oxygen concentration. The proper mechanism might be that 5% oxygen up-regulated HIF-1α expression. HIF-1α subsequently increased the BCL-2 mRNA expression and decreased the BAX mRNA expression in yak COCs and blastocysts, whereas CDX2, POU5F1, SOX2, and NANOG mRNA expressions in blastocysts were significantly increased [158,159,160].
Li Ruizhe compared the expression differences in the transcriptome of yak oocytes at 5% and 20% oxygen concentrations and revealed that the genes up-regulated in the 5% group were mainly involved in hypoxia response, the cell cycle, chromatin conformation and remodeling, and the cytoskeleton, including the WDR26, MKP2K1, MAPK1, TICRR, WAC, EIF4ENIF1, ODC1, CHAMP1, MKI67, MCM10, SFMBT1, PBRM1, KAT8, IQGAP2, EPS8, and RANBP9 genes. The genes up-regulated in the 20% oxygen concentration group, including ACAT1, ATP5MF, AURKAIP1, COX6A1, NDUFA10, NDUFA11, NDUFS7, LYRM7, UQCR10, EIF1AX, RPL13, RPL13A, RPL34, RPLP2, GSTA2, QARS, NOSTRIN, SH3BGRL3, TIMP1, S100A11, and PTX3, were primarily involved in energy metabolism, protein synthesis, redox homeostasis, and oocyte regulation [100]. Additionally, Li Ruizhe et al. discovered that 5% O2 increased the oocyte maturation rate and GSH content, decreased the oocyte ROS level, and improved the quality of PA and IVF blastocysts. The effects were achieved by decreasing the expressions of the antioxidant genes CAT and GPX1, increasing the expression of the metabolism-related gene LDHA, and embryo development-related genes CDX2 and OCT4 in yak IVF blastocysts [100,161].

6. Discussion

Various endogenous, exogenous and environmental factors that regulate yak oocyte and embryo development in vitro have also been reported to play important roles in regulating bovine oocyte and embryo development [162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181].
However, the concentration or molecular mechanism of these factors to exert their optimal effects on oocyte and embryo development in bovines are somewhat different from those in yaks. For example, the optimal concentrations of FGF10 and LIF in promoting oocyte and embryo development in yaks were 5 ng/mL and 50 ng/mL [6,84], respectively, while in bovines, the optimum concentrations of these two factors were 2.5 ng/mL and 25 ng/mL, respectively [164,165]. In yaks, melatonin reduces the level of intracellular ROS through its antioxidant activity, thus reducing cellular ROS levels, inhibiting cell apoptosis and increasing the oocyte maturation rate and IVF embryo cleavage and blastocyst rates [98,99], however, in bovines, melatonin mainly promotes oocyte and embryo development in vitro by up-regulating the expression of GJA4 to enhance gap junction intercellular communication [166]. Whether these differences are due to differences between species needs further study.
The number of factors that regulate oocyte and embryo development in yaks is still far less than that in traditional domestic animals, such as bovines and pigs. Furthermore, current studies mainly focus on the effects of different factors in the maturation and developmental competence of yak oocytes in vitro; little is known about the related molecular mechanisms. As the yak is an atypical animal living on the plateau, the difficulty of sample collection brought great obstacles to the preparation of experimental materials. In addition, the individual differences between different yaks greatly interfere with the accuracy of experimental results. These problems need to be solved urgently in the field of yak breeding in the future.

7. Conclusions

High-quality oocytes are the basis of the application of assisted reproductive technology in livestock breeding. The various factors that influence the maturation and developmental competence of yak oocytes in vitro summarized here will help researchers to further optimize the conditions of IVM of yak oocytes in vitro, thus promoting the improvement of yak breeding and the development of animal husbandry in the plateau area.

Author Contributions

Conceptualization, L.M., S.Y. and J.L.; methodology, J.M.; resources, Y.X. and X.X.; writing—original draft preparation, L.M. and S.Y.; writing—review and editing, D.L., S.Y. and J.L.; supervision, J.L. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the Key Research and Development Program of the Sichuan Provincial Science and Technology Program (2023YFN0001) and Fundamental Research Funds for the Central Universities, Southwest Minzu University (ZYN2023044).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

We thank the Home for Researchers editorial team (www.home-for-researchers.com, accessed on 15 August 2023) for language editing service.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhou, J.; Yue, S.; Du, J.; Xue, B.; Wang, L.; Peng, Q.; Zou, H.; Hu, R.; Jiang, Y.; Wang, Z.; et al. Integration of transcriptomic and metabolomic analysis of the mechanism of dietary N-carbamoylglutamate in promoting follicle development in yaks. Front. Vet. Sci. 2022, 9, 946893. [Google Scholar] [CrossRef] [PubMed]
  2. Zi, X.D. Reproduction in female yaks (Bos grunniens) and opportunities for improvement. Theriogenology 2003, 59, 1303–1312. [Google Scholar] [CrossRef] [PubMed]
  3. Ma, J.; Shah, A.M.; Wang, Z.; Hu, R.; Zou, H.; Wang, X.; Cao, G.; Peng, Q.; Xue, B.; Wang, L.; et al. Comparing the gastrointestinal barrier function between growth-retarded and normal yaks on the Qinghai-Tibetan Plateau. PeerJ 2020, 8, e9851. [Google Scholar] [CrossRef] [PubMed]
  4. Yang, X.; Ma, J.; Mo, L.; Xiong, Y.; Xiong, X.; Lan, D.; Fu, W.; Yin, S. Molecular cloning and characterization of STC1 gene and its functional analyses in yak (Bos grunniens) cumulus granulosa cells. Theriogenology 2023, 208, 185–193. [Google Scholar] [CrossRef]
  5. Yin, S.; Zhou, J.; Yang, L.; Yuan, Y.; Xiong, X.; Lan, D.; Li, J. Identification of microRNA transcriptome throughout the lifespan of yak (Bos grunniens) corpus luteum. Anim. Biotechnol. 2023, 34, 143–155. [Google Scholar] [CrossRef]
  6. Pan, Y.; Wang, M.; Baloch, A.R.; Zhang, Q.; Wang, J.; Ma, R.; Xu, G.; Kashif, J.; Wang, L.; Fan, J.; et al. FGF10 enhances yak oocyte fertilization competence and subsequent blastocyst quality and regulates the levels of CD9, CD81, DNMT1, and DNMT3B. J. Cell. Physiol. 2019, 234, 17677–17689. [Google Scholar] [CrossRef]
  7. Niu, H.R.; Zi, X.D.; Xiao, X.; Xiong, X.R.; Zhong, J.C.; Li, J.; Wang, L.; Wang, Y. Developmental competence of frozen-thawed yak (Bos grunniens) oocytes followed by in vitro maturation and fertilization. Cryobiology 2014, 68, 152–154. [Google Scholar] [CrossRef]
  8. Li, Y.; Dai, Y.; Du, W.; Zhao, C.; Wang, L.; Wang, H.; Liu, Y.; Li, R.; Li, N. In vitro development of yak (Bos grunniens) embryos generated by interspecies nuclear transfer. Anim. Reprod. Sci. 2007, 101, 45–59. [Google Scholar] [CrossRef]
  9. Li, Y.; Li, S.; Dai, Y.; Du, W.; Zhao, C.; Wang, L.; Wang, H.; Li, R.; Liu, Y.; Wan, R.; et al. Nuclear reprogramming in embryos generated by the transfer of yak (Bos grunniens) nuclei into bovine oocytes and comparison with bovine-bovine SCNT and bovine IVF embryos. Theriogenology 2007, 67, 1331–1338. [Google Scholar] [CrossRef]
  10. Das, D.; Arur, S. Regulation of oocyte maturation: Role of conserved ERK signaling. Mol. Reprod. Dev. 2022, 89, 353–374. [Google Scholar] [CrossRef]
  11. Yin, S.; Jiang, X.; Jiang, H.; Gao, Q.; Wang, F.; Fan, S.; Khan, T.; Jabeen, N.; Khan, M.; Ali, A.; et al. Histone acetyltransferase KAT8 is essential for mouse oocyte development by regulating reactive oxygen species levels. Development 2017, 144, 2165–2174. [Google Scholar] [CrossRef]
  12. Sen, A.; Caiazza, F. Oocyte maturation: A story of arrest and release. Front. Biosci. (Schol. Ed.) 2013, 5, 451–477. [Google Scholar] [CrossRef] [PubMed]
  13. Duncan, F.E.; Gerton, J.L. Mammalian oogenesis and female reproductive aging. Aging 2018, 10, 162–163. [Google Scholar] [CrossRef] [PubMed]
  14. Telfer, E.E.; Andersen, C.Y. In vitro growth and maturation of primordial follicles and immature oocytes. Fertil. Steril. 2021, 115, 1116–1125. [Google Scholar] [CrossRef] [PubMed]
  15. Strączyńska, P.; Papis, K.; Morawiec, E.; Czerwiński, M.; Gajewski, Z.; Olejek, A.; Bednarska-Czerwińska, A. Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes. Reprod. Biol. Endocrinol. 2022, 20, 37. [Google Scholar] [CrossRef]
  16. Llonch, S.; Barragán, M.; Nieto, P.; Mallol, A.; Elosua-Bayes, M.; Lorden, P.; Ruiz, S.; Zambelli, F.; Heyn, H.; Vassena, R.; et al. Single human oocyte transcriptome analysis reveals distinct maturation stage-dependent pathways impacted by age. Aging Cell 2021, 20, e13360. [Google Scholar] [CrossRef]
  17. Alcoba, D.D.; Pimentel, A.M.; Brum, I.S.; Corleta, H.E. Developmental potential of in vitro or in vivo matured oocytes. Zygote 2015, 23, 93–98. [Google Scholar] [CrossRef]
  18. Kim, D.H.; Ko, D.S.; Lee, H.C.; Lee, H.J.; Park, W.I.; Kim, S.S.; Park, J.K.; Yang, B.C.; Park, S.B.; Chang, W.K.; et al. Comparison of maturation, fertilization, development, and gene expression of mouse oocytes grown in vitro and in vivo. J. Assist. Reprod. Genet. 2004, 21, 233–240. [Google Scholar] [CrossRef]
  19. Liu, B. Optimization of Yak In-Vitro Embryo Production and Analysis of Apoptosis. Ph.D. Thesis, Gansu Agricultural University, Lanzhou, China, 2013. [Google Scholar]
  20. Yan, P.; Guo, X.; Xv, B.Z.; En, R.; Zeng, Y.F. White yak oocyte maturation in vitro. China Herbiv. Sci. 2006, 04, 7–9. [Google Scholar]
  21. Yan, P.; Xv, B.Z.; Guo, X.; Pan, H.P. In vitro maturation of yak oocytes. Anim. Husb. Vet. Med. 2006, 38, 14–16. [Google Scholar]
  22. Li, T.Q. Oocytes In Vitro Maturation of Tianzhu White Yak. Master’s Thesis, Gansu Agricultural University, Lanzhou, China, 2008. [Google Scholar]
  23. Wang, Y.H.; SuoLang, S.Z.; Gong, G.; Wang, G.; Wang, D.J.; Xv, Y.; Duan, Y.F. In vitro mature culture of Nyingchi yak oocytes. J. Plateau Agric. 2018, 2, 40–43. [Google Scholar] [CrossRef]
  24. Gegenfurtner, K.; Flenkenthaler, F.; Fröhlich, T.; Wolf, E.; Arnold, G.J. The impact of transcription inhibition during in vitro maturation on the proteome of bovine oocytes. Biol. Reprod. 2020, 103, 1000–1011. [Google Scholar] [CrossRef] [PubMed]
  25. Andreu-Vieyra, C.; Lin, Y.N.; Matzuk, M.M. Mining the oocyte transcriptome. Trends Endocrinol. Metab. 2006, 17, 136–143. [Google Scholar] [CrossRef] [PubMed]
  26. Rodriguez, K.F.; Farin, C.E. Gene transcription and regulation of oocyte maturation. Reprod. Fertil. Dev. 2004, 16, 55–67. [Google Scholar] [CrossRef]
  27. Pei, J.; Xiong, L.; Guo, S.; Wang, X.; Bao, P.; Wu, X.; Yan, P.; Guo, X. A single-cell transcriptomic atlas characterizes cell types and their molecular features in yak ovarian cortex. Faseb J. 2023, 37, e22718. [Google Scholar] [CrossRef]
  28. Lan, D.L.; Xiong, X.R.; Lin, B.S.; Chen, Y.B.; Hu, M.; Su, X.S.; Li, J. Transcriptome analysis of yak mataphase Ⅱ (MⅡ) oocytes by a micro-tanscriptome sequencing method. Acta Vet. Zootech. Sin. 2014, 45, 722–732. [Google Scholar]
  29. Lan, D.L.; Xiong, X.R.; Chen, Y.B.; Ai, Y.; Li, J.; MIPAM Tserang-donko. Differential transcriptome analysis of yak oocytes in vitro maturation. Sci. Sin. (Vitea) 2017, 47, 1099–1112. [Google Scholar]
  30. Zhao, Y.L.; Fu, Q.; Chen, F.M.; Zhang, J.; Ren, Z.L. Proteomic profile identification and analysis of Tibet yak oocytes. Chin. J. Vet. Sci. 2018, 38, 1804–1809. [Google Scholar] [CrossRef]
  31. Huang, Y. iTRAQ-Based Comparative Proteomic Analysis of Oocytes In Vitro Maturation for Yak. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2016. [Google Scholar]
  32. Feinberg, A.P. The Key Role of Epigenetics in Human Disease Prevention and Mitigation. N. Engl. J. Med. 2018, 378, 1323–1334. [Google Scholar] [CrossRef]
  33. Zhang, Y.; Sun, Z.; Jia, J.; Du, T.; Zhang, N.; Tang, Y.; Fang, Y.; Fang, D. Overview of Histone Modification. Adv. Exp. Med. Biol. 2021, 1283, 1–16. [Google Scholar] [CrossRef]
  34. Schübeler, D. Function and information content of DNA methylation. Nature 2015, 517, 321–326. [Google Scholar] [CrossRef] [PubMed]
  35. Golding, M.C.; Williamson, G.L.; Stroud, T.K.; Westhusin, M.E.; Long, C.R. Examination of DNA methyltransferase expression in cloned embryos reveals an essential role for Dnmt1 in bovine development. Mol. Reprod. Dev. 2011, 78, 306–317. [Google Scholar] [CrossRef] [PubMed]
  36. Okano, M.; Bell, D.W.; Haber, D.A.; Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99, 247–257. [Google Scholar] [CrossRef] [PubMed]
  37. Saitou, M.; Kagiwada, S.; Kurimoto, K. Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells. Development 2012, 139, 15–31. [Google Scholar] [CrossRef]
  38. Li, Q. Application of Ascorbic Aicd in the Regulation of DNA Methylation in Yak Oocytes and IVF Embryos. Ph.D. Thesis, Gansu Agricultural University, Lanzhou, China, 2020. [Google Scholar]
  39. Li, Q.; Pan, Y.; He, H.; Hu, X.; Zhao, T.; Jiang, J.; Cui, Y.; Xu, G.; Wang, L.; He, J.; et al. DNA methylation regulated by ascorbic acids in yak preimplantation embryo helps to improve blastocyst quality. Mol. Reprod. Dev. 2019, 86, 1138–1148. [Google Scholar] [CrossRef]
  40. Yoshizawa-Sugata, N.; Masai, H. Histone Modification Analysis of Low-Mappability Regions. Methods Mol. Biol. 2023, 2519, 163–185. [Google Scholar] [CrossRef]
  41. Lawrence, M.; Daujat, S.; Schneider, R. Lateral Thinking: How Histone Modifications Regulate Gene Expression. Trends Genet. 2016, 32, 42–56. [Google Scholar] [CrossRef]
  42. Kooistra, S.M.; Helin, K. Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 2012, 13, 297–311. [Google Scholar] [CrossRef]
  43. Wu, Y.W.; Li, S.; Zheng, W.; Li, Y.C.; Chen, L.; Zhou, Y.; Deng, Z.Q.; Lin, G.; Fan, H.Y.; Sha, Q.Q. Dynamic mRNA degradome analyses indicate a role of histone H3K4 trimethylation in association with meiosis-coupled mRNA decay in oocyte aging. Nat. Commun. 2022, 13, 3191. [Google Scholar] [CrossRef]
  44. He, M.; Zhang, T.; Yang, Y.; Wang, C. Mechanisms of Oocyte Maturation and Related Epigenetic Regulation. Front. Cell Dev. Biol. 2021, 9, 654028. [Google Scholar] [CrossRef]
  45. Dahl, J.A.; Jung, I.; Aanes, H.; Greggains, G.D.; Manaf, A.; Lerdrup, M.; Li, G.; Kuan, S.; Li, B.; Lee, A.Y.; et al. Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. Nature 2016, 537, 548–552. [Google Scholar] [CrossRef] [PubMed]
  46. Kong, L.; Zhang, P.; Li, W.; Yang, Y.; Tian, Y.; Wang, X.; Chen, S.; Yang, Y.; Huang, T.; Zhao, T.; et al. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells. Oncotarget 2016, 7, 27959–27974. [Google Scholar] [CrossRef] [PubMed]
  47. Han, J. Analysis of the Expression Profile of Yak KDM1A and Its Effect on Meiosis Maturation of Oocyte. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2019. [Google Scholar]
  48. Han, J.; Xiong, X.R.; Xiong, Y.; Wu, J.B.; Li, J. Effects of KDM1A on the meiotic maturation and develomental potential of yak oocytes. Acta Vet. Zootechica Sin. 2020, 51, 2433–2442. [Google Scholar]
  49. Tsukada, Y.; Fang, J.; Erdjument-Bromage, H.; Warren, M.E.; Borchers, C.H.; Tempst, P.; Zhang, Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006, 439, 811–816. [Google Scholar] [CrossRef] [PubMed]
  50. Cai, W.Y. The Study of Cloning, Expression Profile of Yak KDM2 and Its Role in the Meiosis of Oocyte. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2018. [Google Scholar]
  51. Ma, R.; Zhang, Y.; Zhang, L.; Han, J.; Rui, R. Sirt1 protects pig oocyte against in vitro aging. Anim. Sci. J. 2015, 86, 826–832. [Google Scholar] [CrossRef] [PubMed]
  52. Iljas, J.D.; Wei, Z.; Homer, H.A. Sirt1 sustains female fertility by slowing age-related decline in oocyte quality required for post-fertilization embryo development. Aging Cell 2020, 19, e13204. [Google Scholar] [CrossRef]
  53. Xiong, X.R.; Wang, Y.; Li, J.; Zi, X.D.; Qiu, X. Effects of SIRT1 on the in vitro maturation and aging of yak oocytes. Acta Vet. Et Zootech. Sin. 2019, 50, 2440–2448. [Google Scholar]
  54. Griffiths-Jones, S.; Grocock, R.J.; van Dongen, S.; Bateman, A.; Enright, A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34, D140–D144. [Google Scholar] [CrossRef]
  55. Zeng, Y.; Yi, R.; Cullen, B.R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA 2003, 100, 9779–9784. [Google Scholar] [CrossRef]
  56. Dehghan, Z.; Mohammadi-Yeganeh, S.; Salehi, M. MiRNA-155 regulates cumulus cells function, oocyte maturation, and blastocyst formation. Biol. Reprod. 2020, 103, 548–559. [Google Scholar] [CrossRef]
  57. Luo, X.; Chen, X.; Lv, Y.; Han, Y.; Qu, X.; Zhang, Y.; Li, X.; Yu, Y.; Jin, Y. MicroRNA-101 regulates oocyte maturation in vitro via targeting HAS2 in porcine cumulus cells. Theriogenology 2022, 187, 119–126. [Google Scholar] [CrossRef] [PubMed]
  58. Tanga, B.M.; Fang, X.; Bang, S.; Seong, G.; De Zoysa, M.; Saadeldin, I.M.; Lee, S.; Cho, J. MiRNA-155 inhibition enhances porcine embryo preimplantation developmental competence by upregulating ZEB2 and downregulating ATF4. Theriogenology 2022, 183, 90–97. [Google Scholar] [CrossRef] [PubMed]
  59. Xiong, X.R.; Lan, D.L.; Li, J.; Zi, X.D.; Li, M.Y. Identification of candidate miRNAs and expression profile of yak oocytes before and after in vitro maturation by high-throughput sequencing. Reprod. Domest. Anim. 2016, 51, 886–894. [Google Scholar] [CrossRef] [PubMed]
  60. Xiong, X.; Yang, M.; Yu, H.; Hu, Y.; Yang, L.; Zhu, Y.; Fei, X.; Pan, B.; Xiong, Y.; Fu, W.; et al. MicroRNA-342-3p regulates yak oocyte meiotic maturation by targeting DNA methyltransferase 1. Reprod. Domest. Anim. 2022, 57, 761–770. [Google Scholar] [CrossRef]
  61. Drew, J.E.; Barrett, P.; Mercer, J.G.; Moar, K.M.; Canet, E.; Delagrange, P.; Morgan, P.J. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J. Neuroendocrinol. 2001, 13, 453–458. [Google Scholar] [CrossRef]
  62. Yao, Y.; Chen, Y.; Xiong, X.R.; Chai, Z.X.; Ji, W.H.; Lan, D.L.; MIPAM Tserang-donko. Study on the expression and subcellular localization of G Protein-coupled Receptor 50 during in vitro maturation process of yak oocytes. China Anim. Husb. Vet. Med. 2021, 48, 3387–3393. [Google Scholar] [CrossRef]
  63. Chen, Y.; Zeng, R.; Kou, J.; Xiong, X.; Yao, Y.; Fu, W.; Yin, S.; Lan, D. GPR50 participates in and promotes yak oocyte maturation: A new potential oocyte regulatory molecule. Theriogenology 2022, 181, 34–41. [Google Scholar] [CrossRef]
  64. Bezerra, F.T.G.; Paulino, L.; Silva, B.R.; Silva, A.W.B.; Souza Batista, A.L.P.; Silva, J.R.V. Effects of epidermal growth factor and progesterone on oocyte meiotic resumption and the expression of maturation-related transcripts during prematuration of oocytes from small and medium-sized bovine antral follicles. Reprod. Fertil. Dev. 2020, 32, 1190–1199. [Google Scholar] [CrossRef]
  65. Muhammad, T.; Li, M.; Wang, J.; Huang, T.; Zhao, S.; Zhao, H.; Liu, H.; Chen, Z.J. Roles of insulin-like growth factor II in regulating female reproductive physiology. Sci. China Life Sci. 2020, 63, 849–865. [Google Scholar] [CrossRef]
  66. Currin, L.; Glanzner, W.G.; Gutierrez, K.; de Macedo, M.P.; Guay, V.; Baldassarre, H.; Bordignon, V. Optimizing swine in vitro embryo production with growth factor and antioxidant supplementation during oocyte maturation. Theriogenology 2022, 194, 133–143. [Google Scholar] [CrossRef]
  67. Richter, K.S. The importance of growth factors for preimplantation embryo development and in-vitro culture. Curr. Opin. Obstet. Gynecol. 2008, 20, 292–304. [Google Scholar] [CrossRef] [PubMed]
  68. Dadi, T.D.; Li, M.W.; Lloyd, K.C. Decreased growth factor expression through RNA interference inhibits development of mouse preimplantation embryos. Comp. Med. 2009, 59, 331–338. [Google Scholar] [PubMed]
  69. Yousef, N.A.; Hussein, H.A.S.; Badr, M.R.; Ahmed, A.E. Effect of Epidermal Growth Factors (EGF) on the Maturation and Developmental Competence of Buffalos’ Oocytes and Embryo Stages In Vitro. SVU-Int. J. Vet. Sci. 2018, 1, 85–94. [Google Scholar] [CrossRef]
  70. Yu, Y.; Yan, J.; Li, M.; Yan, L.; Zhao, Y.; Lian, Y.; Li, R.; Liu, P.; Qiao, J. Effects of combined epidermal growth factor, brain-derived neurotrophic factor and insulin-like growth factor-1 on human oocyte maturation and early fertilized and cloned embryo development. Hum. Reprod. 2012, 27, 2146–2159. [Google Scholar] [CrossRef] [PubMed]
  71. Warzych, E.; Peippo, J.; Szydlowski, M.; Lechniak, D. Supplements to in vitro maturation media affect the production of bovine blastocysts and their apoptotic index but not the proportions of matured and apoptotic oocytes. Anim. Reprod. Sci. 2007, 97, 334–343. [Google Scholar] [CrossRef]
  72. Ma, L.; Yuan, N. The effect of in vitro culture time and EGF on the yak oocyte maturation and parthenogenetic embryos in vitro development. J. Southwest Minzu Univ. (Nat. Sci. Ed.) 2013, 39, 865–868. [Google Scholar]
  73. Pan, Y.Y.; Li, Q.; Cui, Y.; Fan, J.F.; Yang, K.; He, J.F.; Yu, S.J. The expression of EGF and EGFR in yak oocyte and its function on development competence of embryo. Sci. Agric. Sin. 2015, 48, 2439–2448. [Google Scholar]
  74. Stuard, W.L.; Titone, R.; Robertson, D.M. The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease. Front. Endocrinol. 2020, 11, 24. [Google Scholar] [CrossRef]
  75. Bailes, J.; Soloviev, M. Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports. Biomolecules 2021, 11, 217. [Google Scholar] [CrossRef]
  76. Pan, Y.; Cui, Y.; He, H.; Baloch, A.R.; Fan, J.; Xu, G.; He, J.; Yang, K.; Li, G.; Yu, S. Developmental competence of mature yak vitrified-warmed oocytes is enhanced by IGF-I via modulation of CIRP during in vitro maturation. Cryobiology 2015, 71, 493–498. [Google Scholar] [CrossRef]
  77. Liu, L.; Shi, Q.; Wang, K.; Qian, Y.; Zhou, L.; Bellusci, S.; Chen, C.; Dong, N. Fibroblast growth factor 10 protects against particulate matter-induced lung injury by inhibiting oxidative stress-mediated pyroptosis via the PI3K/Akt/Nrf2 signaling pathway. Int. Immunopharmacol. 2022, 113, 109398. [Google Scholar] [CrossRef] [PubMed]
  78. Itoh, N. FGF10: A multifunctional mesenchymal-epithelial signaling growth factor in development, health, and disease. Cytokine Growth Factor Rev. 2016, 28, 63–69. [Google Scholar] [CrossRef] [PubMed]
  79. Upadhyay, D.; Panduri, V.; Kamp, D.W. Fibroblast growth factor-10 prevents asbestos-induced alveolar epithelial cell apoptosis by a mitogen-activated protein kinase-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 2005, 32, 232–238. [Google Scholar] [CrossRef] [PubMed]
  80. Jiang, T.; Hu, W.; Zhang, S.; Ren, C.; Lin, S.; Zhou, Z.; Wu, H.; Yin, J.; Tan, L. Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis. Respir. Res. 2022, 23, 269. [Google Scholar] [CrossRef]
  81. Chaves, R.N.; Lima-Verde, I.B.; Celestino, J.J.; Duarte, A.B.; Alves, A.M.; Matos, M.H.; Campello, C.C.; Name, K.P.; Báo, S.N.; Buratini, J., Jr.; et al. Fibroblast growth factor-10 maintains the survival and promotes the growth of cultured goat preantral follicles. Domest. Anim. Endocrinol. 2010, 39, 249–258. [Google Scholar] [CrossRef]
  82. Du, S.; Liu, X.; Deng, K.; Zhou, W.; Lu, F.; Shi, D. The expression pattern of fibroblast growth factor 10 and its receptors during buffalo follicular development. Int. J. Clin. Exp. Pathol. 2018, 11, 4934–4941. [Google Scholar]
  83. Rose-John, S. Interleukin-6 Family Cytokines. Cold Spring Harb. Perspect. Biol. 2018, 10, a028415. [Google Scholar] [CrossRef]
  84. Zhao, T.; Pan, Y.; Li, Q.; Ding, T.; Niayale, R.; Zhang, T.; Wang, J.; Wang, Y.; Zhao, L.; Han, X.; et al. Leukemia inhibitory factor enhances the development and subsequent blastocysts quality of yak oocytes in vitro. Front. Vet. Sci. 2022, 9, 997709. [Google Scholar] [CrossRef]
  85. Cao, B.; Qin, J.; Pan, B.; Qazi, I.H.; Ye, J.; Fang, Y.; Zhou, G. Oxidative Stress and Oocyte Cryopreservation: Recent Advances in Mitigation Strategies Involving Antioxidants. Cells 2022, 11, 3573. [Google Scholar] [CrossRef]
  86. Jones, D.P. Redefining oxidative stress. Antioxid. Redox Signal 2006, 8, 1865–1879. [Google Scholar] [CrossRef]
  87. Wang, L.; Tang, J.; Wang, L.; Tan, F.; Song, H.; Zhou, J.; Li, F. Oxidative stress in oocyte aging and female reproduction. J. Cell. Physiol. 2021, 236, 7966–7983. [Google Scholar] [CrossRef] [PubMed]
  88. Prasad, S.; Tiwari, M.; Pandey, A.N.; Shrivastav, T.G.; Chaube, S.K. Impact of stress on oocyte quality and reproductive outcome. J. Biomed. Sci. 2016, 23, 36. [Google Scholar] [CrossRef] [PubMed]
  89. Bar-El Dadon, S.; Reifen, R. Vitamin A and the epigenome. Crit. Rev. Food Sci. Nutr. 2017, 57, 2404–2411. [Google Scholar] [CrossRef] [PubMed]
  90. Ikeda, S.; Kitagawa, M.; Imai, H.; Yamada, M. The roles of vitamin A for cytoplasmic maturation of bovine oocytes. J. Reprod. Dev. 2005, 51, 23–35. [Google Scholar] [CrossRef] [PubMed]
  91. Feng, C.W.; Burnet, G.; Spiller, C.M.; Cheung, F.K.M.; Chawengsaksophak, K.; Koopman, P.; Bowles, J. Identification of regulatory elements required for Stra8 expression in fetal ovarian germ cells of the mouse. Development 2021, 148, dev194977. [Google Scholar] [CrossRef] [PubMed]
  92. Manku, G.; Wang, Y.; Merkbaoui, V.; Boisvert, A.; Ye, X.; Blonder, J.; Culty, M. Role of retinoic acid and platelet-derived growth factor receptor cross talk in the regulation of neonatal gonocyte and embryonal carcinoma cell differentiation. Endocrinology 2015, 156, 346–359. [Google Scholar] [CrossRef]
  93. Ji, W.H.; Wang, Y.L.; He, H.H.; Fu, W.; Lan, D.L. Effects of vitamin A on the maturation and subsequent development of yak oocytes in vitro. China Anim. Husb. Vet. Med. 2022, 49, 4707–4714. [Google Scholar] [CrossRef]
  94. Wang, Y.L. A Preliminary Study on the Effect of Vitamin A on the Maturation of Yak Oocytes In Vitro and Its Mechanism of Actin. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2022. [Google Scholar]
  95. Knight, J.; Madduma-Liyanage, K.; Mobley, J.A.; Assimos, D.G.; Holmes, R.P. Ascorbic acid intake and oxalate synthesis. Urolithiasis 2016, 44, 289–297. [Google Scholar] [CrossRef]
  96. Li, Q.; Zhao, T.; He, H.; Robert, N.; Ding, T.; Hu, X.; Zhang, T.; Pan, Y.; Cui, Y.; Yu, S. Ascorbic acid protects the toxic effects of aflatoxin B(1) on yak oocyte maturation. Anim. Sci. J. 2022, 93, e13702. [Google Scholar] [CrossRef]
  97. Reiter, R.J.; Tan, D.X.; Fuentes-Broto, L. Melatonin: A multitasking molecule. Prog. Brain Res. 2010, 181, 127–151. [Google Scholar] [CrossRef]
  98. Peng, W.; Huang, R.; Shu, S.; Xv, S.R.; Zhang, J. Research of metatonin inhibits oxidative stress and promotes oocyte maturation of yak in vitro. Chin. Qinghai J. Anim. Vet. Sci. 2021, 51, 1–6+66. [Google Scholar]
  99. Peng, W. Analysis of Ovarian Differences in Cold and Warm Season and the Effects of Melatonin on Oocyte Maturation and Embryo Development of Yak In Vitro. Ph.D. Thesis, Northwest A&F University, Xianyang, China, 2019. [Google Scholar]
  100. Li, R.Z. Effects and Mechanisms of Low Oxygen Concentration on In Vitro Maturation and Developmental Competence of Yak Oocytes. Ph.D. Thesis, Gansu Agricultural University, Lanzhou, China, 2021. [Google Scholar]
  101. Benazic, S.; Silconi, Z.B.; Jevtovic, A.; Jurisevic, M.; Milovanovic, J.; Mijajlovic, M.; Nikolic, M.; Kanjevac, T.; Potočňák, I.; Samoľová, E.; et al. The Zn(S-pr-thiosal)(2) complex attenuates murine breast cancer growth by inducing apoptosis and G1/S cell cycle arrest. Future Med. Chem. 2020, 12, 897–914. [Google Scholar] [CrossRef] [PubMed]
  102. Bonaventura, P.; Benedetti, G.; Albarède, F.; Miossec, P. Zinc and its role in immunity and inflammation. Autoimmun. Rev. 2015, 14, 277–285. [Google Scholar] [CrossRef] [PubMed]
  103. Xiong, X.; Lan, D.; Li, J.; Lin, Y.; Zi, X. Effects of Zinc Supplementation During In Vitro Maturation on Meiotic Maturation of Oocytes and Developmental Capacity in Yak. Biol. Trace Elem. Res. 2018, 185, 89–97. [Google Scholar] [CrossRef] [PubMed]
  104. Hu, J.J. Effects of Zinc Supplementation on Meiosis Maturation and Development of Yak Oocytes. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2017. [Google Scholar]
  105. Feng, Y.; Zhao, X.; Ruan, Z.Y.; Shen, P.L.; Shi, D.S.; Lu, F.H. Effects of Zinc on bovine oocytes in vitro maturation and early embryonic development. Chin. J. Anim. Sci. 2019, 55, 14–19. [Google Scholar] [CrossRef]
  106. Clapham, D.E. Calcium signaling. Cell 2007, 131, 1047–1058. [Google Scholar] [CrossRef]
  107. Chen, Z. Mechanism of Ca2+ Regulating Maturation through CaMKⅡ in Yak. Master’s Thesis, Northwest Minzu University, Lanzhou, China, 2022. [Google Scholar]
  108. Saito, Y.; Yoshida, Y.; Akazawa, T.; Takahashi, K.; Niki, E. Cell death caused by selenium deficiency and protective effect of antioxidants. J. Biol. Chem. 2003, 278, 39428–39434. [Google Scholar] [CrossRef]
  109. Zeng, H. Selenium as an essential micronutrient: Roles in cell cycle and apoptosis. Molecules 2009, 14, 1263–1278. [Google Scholar] [CrossRef]
  110. Avery, J.C.; Hoffmann, P.R. Selenium, Selenoproteins, and Immunity. Nutrients 2018, 10, 1203. [Google Scholar] [CrossRef]
  111. Xiong, X.; Lan, D.; Li, J.; Lin, Y.; Li, M. Selenium supplementation during in vitro maturation enhances meiosis and developmental capacity of yak oocytes. Anim. Sci. J. 2018, 89, 298–306. [Google Scholar] [CrossRef]
  112. Zhang, H.; Kong, Q.; Wang, J.; Jiang, Y.; Hua, H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp. Hematol. Oncol. 2020, 9, 32. [Google Scholar] [CrossRef] [PubMed]
  113. Pan, B.; Li, J. The art of oocyte meiotic arrest regulation. Reprod. Biol. Endocrinol. 2019, 17, 8. [Google Scholar] [CrossRef] [PubMed]
  114. Appeltant, R.; Somfai, T.; Maes, D.; Van Soom, A.; Kikuchi, K. Porcine oocyte maturation in vitro: Role of cAMP and oocyte-secreted factors—A practical approach. J. Reprod. Dev. 2016, 62, 439–449. [Google Scholar] [CrossRef] [PubMed]
  115. Yang, C.R.; Wei, Y.; Qi, S.T.; Chen, L.; Zhang, Q.H.; Ma, J.Y.; Luo, Y.B.; Wang, Y.P.; Hou, Y.; Schatten, H.; et al. The G protein coupled receptor 3 is involved in cAMP and cGMP signaling and maintenance of meiotic arrest in porcine oocytes. PLoS ONE 2012, 7, e38807. [Google Scholar] [CrossRef]
  116. Vaccari, S.; Horner, K.; Mehlmann, L.M.; Conti, M. Generation of mouse oocytes defective in cAMP synthesis and degradation: Endogenous cyclic AMP is essential for meiotic arrest. Dev. Biol. 2008, 316, 124–134. [Google Scholar] [CrossRef]
  117. Ramos Leal, G.; Santos Monteiro, C.A.; Souza-Fabjan, J.M.G.; de Paula Vasconcelos, C.O.; Garcia Nogueira, L.A.; Reis Ferreira, A.M.; Varella Serapião, R. Role of cAMP modulator supplementations during oocyte in vitro maturation in domestic animals. Anim. Reprod. Sci. 2018, 199, 1–14. [Google Scholar] [CrossRef]
  118. Ozturk, S. Molecular determinants of the meiotic arrests in mammalian oocytes at different stages of maturation. Cell Cycle 2022, 21, 547–571. [Google Scholar] [CrossRef]
  119. Xiong, X.R.; Lan, D.L.; Li, J.; Lin, Y.Q.; Li, M.Y. Supplementation of cilostazol during in vitro maturation enhances the meiosis and developmental competence of yak oocytes by influencing cAMP content and mRNA expression. Anim. Reprod. Sci. 2017, 186, 21–30. [Google Scholar] [CrossRef]
  120. Wesierska-Gadek, J.; Kramer, M.P.; Maurer, M. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food Chem. Toxicol. 2008, 46, 1327–1333. [Google Scholar] [CrossRef]
  121. Liu, Y. The Effects of Roscovitine on Granulosa Cell Culture and Oocyte In Vitro Maturation of the Yak. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2022. [Google Scholar]
  122. Caixeta, F.M.; Sousa, R.V.; Guimarães, A.L.; Leme, L.O.; Sprícigo, J.F.; Netto, S.B.; Pivato, I.; Dode, M.A. Meiotic arrest as an alternative to increase the production of bovine embryos by somatic cell nuclear transfer. Zygote 2017, 25, 32–40. [Google Scholar] [CrossRef]
  123. Jing, T. The Effects of CNP on Oocyte Maturation and Embryo Development of the Yak. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2021. [Google Scholar]
  124. Wang, Q.; Ratchford, A.M.; Chi, M.M.; Schoeller, E.; Frolova, A.; Schedl, T.; Moley, K.H. Maternal diabetes causes mitochondrial dysfunction and meiotic defects in murine oocytes. Mol. Endocrinol. 2009, 23, 1603–1612. [Google Scholar] [CrossRef] [PubMed]
  125. Paczkowski, M.; Silva, E.; Schoolcraft, W.B.; Krisher, R.L. Comparative importance of fatty acid beta-oxidation to nuclear maturation, gene expression, and glucose metabolism in mouse, bovine, and porcine cumulus oocyte complexes. Biol. Reprod. 2013, 88, 111. [Google Scholar] [CrossRef] [PubMed]
  126. Paczkowski, M.; Schoolcraft, W.B.; Krisher, R.L. Fatty acid metabolism during maturation affects glucose uptake and is essential to oocyte competence. Reproduction 2014, 148, 429–439. [Google Scholar] [CrossRef] [PubMed]
  127. Sutton-McDowall, M.L.; Gilchrist, R.B.; Thompson, J.G. The pivotal role of glucose metabolism in determining oocyte developmental competence. Reproduction 2010, 139, 685–695. [Google Scholar] [CrossRef]
  128. Dang-Nguyen, T.Q.; Nguyen, H.T.; Somfai, T.; Wells, D.; Men, N.T.; Viet-Linh, N.; Noguchi, J.; Kaneko, H.; Kikuchi, K.; Nagai, T. Sucrose assists selection of high-quality oocytes in pigs. Anim. Sci. J. 2018, 89, 880–887. [Google Scholar] [CrossRef]
  129. De Santis, L.; Cino, I.; Rabellotti, E.; Papaleo, E.; Calzi, F.; Fusi, F.M.; Brigante, C.; Ferrari, A. Oocyte cryopreservation: Clinical outcome of slow-cooling protocols differing in sucrose concentration. Reprod. Biomed. Online 2007, 14, 57–63. [Google Scholar] [CrossRef]
  130. Ongaratto, F.L.; Rodriguez-Villamil, P.; Bertolini, M.; Carlson, D.F. Influence of oocyte selection, activation with a zinc chelator and inhibition of histone deacetylases on cloned porcine embryo and chemically activated oocytes development. Zygote 2020, 28, 286–290. [Google Scholar] [CrossRef]
  131. Shi, X.; Xiong, X.R.; Lan, D.L.; Hu, J.J.; Cai, W.Y.; Zhang, D.W.; Li, J. Effect of sugar on in vitro maturation and development competence of yak oocytes. China Anim. Husb. Vet. Meducine 2017, 44, 155–160. [Google Scholar] [CrossRef]
  132. Xiao, X.; Zi, X.D.; Niu, H.R.; Xiong, X.R.; Zhong, J.C.; Li, J.; Wang, L.; Wang, Y. Effect of addition of FSH, LH and proteasome inhibitor MG132 to in vitro maturation medium on the developmental competence of yak (Bos grunniens) oocytes. Reprod. Biol. Endocrinol. 2014, 12, 30. [Google Scholar] [CrossRef]
  133. He, H.H.; Pan, Y.Y.; Zhang, H.Z.; Li, Q.; Wang, M.; Cui, Y.; Fan, J.F.; Yu, S.J. The effects of Follicle-stimulating Hormone (FSH) on the expression of EGF and EGFR in yak oocytes and apoptpsis. Acta Vet. Zootech. Sin. 2018, 49, 1899–1907. [Google Scholar]
  134. Krasnow, J.S.; Hickey, G.J.; Richards, J.S. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol. Endocrinol. 1990, 4, 13–21. [Google Scholar] [CrossRef] [PubMed]
  135. Duan, J.X. The Effect and Regulation of Estrogen to Autophagy in Procine Oocyte. Ph.D. Thesis, Northwest A&F University, Xianyang, China, 2021. [Google Scholar]
  136. Yang, B.X. Study on the Role of Estradiol in Ovine Cumulus-Oocyte Complexes Cultured In Vitro. Master’s Thesis, Inner Mongolia Agricultural University, Hohhot, China, 2021. [Google Scholar]
  137. Lv, L.H.; Li, F.Z.; Yue, W.B. Effect of different concentrations of estradiol added to maturation fluid on the maturation of goat oocytes. Heilongjiang Anim. Sci. Vet. Med. 2008, 37–38. [Google Scholar] [CrossRef]
  138. Jin, H.X.; Sun, Y.P.; Xin, Z.M.; Su, Y.C.; Guo, Y.H. Effects of 17 beta-estradiol on maturation and embryo development competence of mouse oocytes in vitro. J. Zhengzhou Univ. (Med. Sci.) 2008, 1137–1139. [Google Scholar] [CrossRef]
  139. Xiao, H.W.; Hua, Z.D.; Zhang, L.P.; Ren, H.Y.; Liu, X.M.; Hua, W.J.; Li, L.; Bi, Y.Z.; Zheng, X.M. Effect of 17-beta-estrodiol (E2) in procine oocytes maturation and fertilized embryos’ development in vitro. Hubei Agric. Sci. 2015, 54, 5660–5661+5665. [Google Scholar] [CrossRef]
  140. Pan, Y.; Wang, M.; Wang, L.; Zhang, Q.; Baloch, A.R.; He, H.; Xu, G.; Soomro, J.; Cui, Y.; Yu, S. Estrogen improves the development of yak (Bos grunniens) oocytes by targeting cumulus expansion and levels of oocyte-secreted factors during in vitro maturation. PLoS ONE 2020, 15, e0239151. [Google Scholar] [CrossRef]
  141. Kriegsfeld, L.J.; Gibson, E.M.; Williams, W.P., 3rd; Zhao, S.; Mason, A.O.; Bentley, G.E.; Tsutsui, K. The roles of RFamide-related peptide-3 in mammalian reproductive function and behaviour. J. Neuroendocrinol. 2010, 22, 692–700. [Google Scholar] [CrossRef]
  142. Mamgain, A.; Sawyer, I.L.; Timajo, D.A.M.; Rizwan, M.Z.; Evans, M.C.; Ancel, C.M.; Inglis, M.A.; Anderson, G.M. RFamide-Related Peptide Neurons Modulate Reproductive Function and Stress Responses. J. Neurosci. 2021, 41, 474–488. [Google Scholar] [CrossRef]
  143. Xiong, X.; Hu, Y.; Pan, B.; Zhu, Y.; Fei, X.; Yang, Q.; Xie, Y.; Xiong, Y.; Lan, D.; Fu, W.; et al. RFRP-3 Influences Apoptosis and Steroidogenesis of Yak Cumulus Cells and Compromises Oocyte Meiotic Maturation and Subsequent Developmental Competence. Int. J. Mol. Sci. 2023, 24, 7000. [Google Scholar] [CrossRef]
  144. Sun, Y.; Wang, M.; Sun, X.J.; Wang, J.L.; Ma, R.; Yu, S.J.; Pan, Y.Y. Differential expression analysis of CYP19A1 during follicular development and oocyte maturation in yaks. Gansu Anim. Husb. Vet. 2021, 51, 37–42. [Google Scholar] [CrossRef]
  145. Wang, L.B.; Wang, M.; Sun, Y.; Chen, R.; Zhang, T.T.; Huang, Z.H.; Zhang, Q.; Yu, S.J.; Pan, Y.Y. CYP19A1 promotes autophagy and early development ability of yak oocytes by regulating the levels of endogenous estradiol. Acta Vet. Zootech. Sin. 2022, 53, 4283–4295. [Google Scholar]
  146. Harper, M.J. Platelet-activating factor: A paracrine factor in preimplantation stages of reproduction? Biol. Reprod. 1989, 40, 907–913. [Google Scholar] [CrossRef] [PubMed]
  147. Tiemann, U. The role of platelet-activating factor in the mammalian female reproductive tract. Reprod. Domest. Anim. 2008, 43, 647–655. [Google Scholar] [CrossRef] [PubMed]
  148. Wang, Q. The Effects of PAF on Oocyte Maturation and Embryo Development of the Yak. Master’s Thesis, Southwest Minzu University, Chengdu, China, 2019. [Google Scholar]
  149. Wang, Q.; Xiong, Y.; Zi, X.D. Effects of PFA supplementation during in vitro maturation medium on yak oocyte development competence and gene expression. Acta Vet. Zootech. Sin. 2020, 51, 514–523. [Google Scholar]
  150. Pang, B.; Zhao, X.Q.; Guo, Z.L.; Qv, L.; Yu, H.H.; Guo, S.C. Influence of different ovary storage temperature on oocyte in vitro maturation and discovery of yak oocyte maturation cultivation methods. Xinjiang Agric. Sci. 2012, 49, 1158–1164. [Google Scholar]
  151. Ma, L.; Li, Z.Q.; Xiong, X.R. The effect of yak ovarian transport condition on the oocytes quality and embryos in vitro development. J. Southwest Minzu Univ. (Nat. Sci. Ed.) 2013, 39, 1–4. [Google Scholar]
  152. Bennemann, J.; Grothmann, H.; Wrenzycki, C. Reduced oxygen concentration during in vitro oocyte maturation alters global DNA methylation in the maternal pronucleus of subsequent zygotes in cattle. Mol. Reprod. Dev. 2018, 85, 849–857. [Google Scholar] [CrossRef]
  153. Fathollahipour, S.; Patil, P.; Leipzig, N. Oxygen Regulation in Development: Lessons from Embryogenesis towards Tissue Engineering. Cells Tissues Organs 2018, 205, 350–371. [Google Scholar] [CrossRef]
  154. Lim, M.; Thompson, J.G.; Dunning, K.R. HYPOXIA AND REPRODUCTIVE HEALTH: Hypoxia and ovarian function: Follicle development, ovulation, oocyte maturation. Reproduction 2021, 161, F33–F40. [Google Scholar] [CrossRef]
  155. Belli, M.; Antonouli, S.; Palmerini, M.G.; Bianchi, S.; Bernardi, S.; Khalili, M.A.; Donfrancesco, O.; Nottola, S.A.; Macchiarelli, G. The effect of low and ultra-low oxygen tensions on mammalian embryo culture and development in experimental and clinical IVF. Syst. Biol. Reprod. Med. 2020, 66, 229–235. [Google Scholar] [CrossRef]
  156. Sánchez-Ajofrín, I.; Iniesta-Cuerda, M.; Sánchez-Calabuig, M.J.; Peris-Frau, P.; Martín-Maestro, A.; Ortiz, J.A.; Del Rocío Fernández-Santos, M.; Garde, J.J.; Gutiérrez-Adán, A.; Soler, A.J. Oxygen tension during in vitro oocyte maturation and fertilization affects embryo quality in sheep and deer. Anim. Reprod. Sci. 2020, 213, 106279. [Google Scholar] [CrossRef]
  157. Hashimoto, S.; Minami, N.; Takakura, R.; Yamada, M.; Imai, H.; Kashima, N. Low oxygen tension during in vitro maturation is beneficial for supporting the subsequent development of bovine cumulus-oocyte complexes. Mol. Reprod. Dev. 2000, 57, 353–360. [Google Scholar] [CrossRef] [PubMed]
  158. He, H.H. Study on the Effect of Low Oxygen Concentration on Developmental Competence of Yak Oocyte Maturation, Pre-Implantation Embryos and Its Mechanisms. Ph.D. Thesis, Gansu Agricultural University, Lanzhou, China, 2020. [Google Scholar]
  159. He, H.; Zhang, H.; Pan, Y.; Zhang, T.; Yang, S.; Liu, M.; Robert, N.; Wang, J.; Zhao, T.; Zhao, L.; et al. Low oxygen concentration improves yak oocyte maturation and inhibits apoptosis through HIF-1 and VEGF. Reprod. Domest. Anim. 2022, 57, 381–392. [Google Scholar] [CrossRef] [PubMed]
  160. He, H.; Zhang, H.; Li, Q.; Fan, J.; Pan, Y.; Zhang, T.; Robert, N.; Zhao, L.; Hu, X.; Han, X.; et al. Low oxygen concentrations improve yak oocyte maturation and enhance the developmental competence of preimplantation embryos. Theriogenology 2020, 156, 46–58. [Google Scholar] [CrossRef]
  161. Li, R.; Luo, Y.; Xu, J.; Sun, Y.; Ma, Z.; Chen, S. Effects of oxygen concentrations on developmental competence and transcriptomic profile of yak oocytes. Zygote 2020, 28, 459–469. [Google Scholar] [CrossRef] [PubMed]
  162. Park, Y.S.; Lin, Y.C. Effect of epidermal growth factor (EGF) and defined simple media on in vitro bovine oocyte maturation and early embryonic development. Theriogenology 1993, 39, 475–484. [Google Scholar] [CrossRef]
  163. Stefanello, J.R.; Barreta, M.H.; Porciuncula, P.M.; Arruda, J.N.; Oliveira, J.F.; Oliveira, M.A.; Gonçalves, P.B. Effect of angiotensin II with follicle cells and insulin-like growth factor-I or insulin on bovine oocyte maturation and embryo development. Theriogenology 2006, 66, 2068–2076. [Google Scholar] [CrossRef]
  164. Pomini Pinto, R.F.; Fontes, P.K.; Loureiro, B.; Sousa Castilho, A.C.; Sousa Ticianelli, J.; Montanari Razza, E.; Satrapa, R.A.; Buratini, J.; Moraes Barros, C. Effects of FGF10 on bovine oocyte meiosis progression, apoptosis, embryo development and relative abundance of developmentally important genes in vitro. Reprod. Domest. Anim. 2015, 50, 84–90. [Google Scholar] [CrossRef]
  165. Mo, X.; Wu, G.; Yuan, D.; Jia, B.; Liu, C.; Zhu, S.; Hou, Y. Leukemia inhibitory factor enhances bovine oocyte maturation and early embryo development. Mol. Reprod. Dev. 2014, 81, 608–618. [Google Scholar] [CrossRef]
  166. Hao, T.; Xu, X.; Hao, H.; Du, W.; Pang, Y.; Zhao, S.; Zou, H.; Yang, S.; Zhu, H.; Yang, Y.; et al. Melatonin improves the maturation and developmental ability of bovine oocytes by up-regulating GJA4 to enhance gap junction intercellular communication. Reprod. Fertil. Dev. 2021, 33, 760–771. [Google Scholar] [CrossRef]
  167. Dalvit, G.; Llanes, S.P.; Descalzo, A.; Insani, M.; Beconi, M.; Cetica, P. Effect of alpha-tocopherol and ascorbic acid on bovine oocyte in vitro maturation. Reprod. Domest. Anim. 2005, 40, 93–97. [Google Scholar] [CrossRef]
  168. Gómez, E.; Caamaño, J.N.; Rodríguez, A.; De Frutos, C.; Facal, N.; Díez, C. Bovine early embryonic development and vitamin A. Reprod. Domest. Anim. 2006, 41 (Suppl. S2), 63–71. [Google Scholar] [CrossRef] [PubMed]
  169. Lodde, V.; Garcia Barros, R.; Dall’Acqua, P.C.; Dieci, C.; Robert, C.; Bastien, A.; Sirard, M.A.; Franciosi, F.; Luciano, A.M. Zinc supports transcription and improves meiotic competence of growing bovine oocytes. Reproduction 2020, 159, 679–691. [Google Scholar] [CrossRef] [PubMed]
  170. Guixue, Z.; Luciano, A.M.; Coenen, K.; Gandolfi, F.; Sirard, M.A. The influence of cAMP before or during bovine oocyte maturation on embryonic developmental competence. Theriogenology 2001, 55, 1733–1743. [Google Scholar] [CrossRef]
  171. Barretto, L.S.; Caiado Castro, V.S.; Garcia, J.M.; Mingoti, G.Z. Role of roscovitine and IBMX on kinetics of nuclear and cytoplasmic maturation of bovine oocytes in vitro. Anim. Reprod. Sci. 2007, 99, 202–207. [Google Scholar] [CrossRef] [PubMed]
  172. Zhang, T.; Zhang, C.; Fan, X.; Li, R.; Zhang, J. Effect of C-type natriuretic peptide pretreatment on in vitro bovine oocyte maturation. In Vitro Cell Dev. Biol. Anim. 2017, 53, 199–206. [Google Scholar] [CrossRef]
  173. De Bie, J.; Marei, W.F.A.; Maillo, V.; Jordaens, L.; Gutierrez-Adan, A.; Bols, P.E.J.; Leroy, J. Differential effects of high and low glucose concentrations during lipolysis-like conditions on bovine in vitro oocyte quality, metabolism and subsequent embryo development. Reprod. Fertil. Dev. 2017, 29, 2284–2300. [Google Scholar] [CrossRef]
  174. Caixeta, E.S.; Machado, M.F.; Ripamonte, P.; Price, C.; Buratini, J. Effects of FSH on the expression of receptors for oocyte-secreted factors and members of the EGF-like family during in vitro maturation in cattle. Reprod. Fertil. Dev. 2013, 25, 890–899. [Google Scholar] [CrossRef]
  175. Beker, A.R.; Colenbrander, B.; Bevers, M.M. Effect of 17beta-estradiol on the in vitro maturation of bovine oocytes. Theriogenology 2002, 58, 1663–1673. [Google Scholar] [CrossRef]
  176. Suttirojpattana, T.; Somfai, T.; Matoba, S.; Nagai, T.; Parnpai, R.; Geshi, M. The effect of temperature during liquid storage of in vitro-matured bovine oocytes on subsequent embryo development. Theriogenology 2016, 85, 509–518.e501. [Google Scholar] [CrossRef]
  177. Bermejo-Alvarez, P.; Lonergan, P.; Rizos, D.; Gutiérrez-Adan, A. Low oxygen tension during IVM improves bovine oocyte competence and enhances anaerobic glycolysis. Reprod. Biomed. Online 2010, 20, 341–349. [Google Scholar] [CrossRef]
  178. Garcia-Herreros, M.; Aparicio, I.M.; Rath, D.; Fair, T.; Lonergan, P. Differential glycolytic and glycogenogenic transduction pathways in male and female bovine embryos produced in vitro. Reprod. Fertil. Dev. 2012, 24, 344–352. [Google Scholar] [CrossRef] [PubMed]
  179. Gutierrez-Reinoso, M.A.; Aponte, P.M.; Garcia-Herreros, M. Genomic Analysis, Progress and Future Perspectives in Dairy Cattle Selection: A Review. Animals 2021, 11, 599. [Google Scholar] [CrossRef] [PubMed]
  180. García-Herreros, M.; Simintiras, C.A.; Lonergan, P. Temporally differential protein expression of glycolytic and glycogenic enzymes during in vitro preimplantation bovine embryo development. Reprod. Fertil. Dev. 2018, 30, 1245–1252. [Google Scholar] [CrossRef] [PubMed]
  181. Aparicio, I.M.; Garcia-Herreros, M.; O’Shea, L.C.; Hensey, C.; Lonergan, P.; Fair, T. Expression, regulation, and function of progesterone receptors in bovine cumulus oocyte complexes during in vitro maturation. Biol. Reprod. 2011, 84, 910–921. [Google Scholar] [CrossRef] [PubMed]
Table 1. Effects of some of exogenous factors on in vitro maturation and development of yak oocytes.
Table 1. Effects of some of exogenous factors on in vitro maturation and development of yak oocytes.
Endogenous FactorModelTreatmentEffectPossible MechanismReference
GPR50-Yak oocyteKnockdown
GPR50
↓ Maturation and polar body 1 excretion rates-[62,63]
Histone modificationsKDM1AYak COCsAdding GSK-KDM1A, the specific inhibitor of KDM1A↓ Cumulus cell expansion, the first polar body excretion rate, and cleavage↑ OCT4
↑ SOX2
[47,48]
KDM2Yak oocyteAdding butyrazide, a specific inhibitor of KDM2↓ Oocyte maturation
↑ Cleavage and blastocyst rates
-[50]
SIRT1Yak COCsAdding the specific agonist SRT2104↑ Cumulus cell expansion, cleavage and blastocyst rates
↑ Early embryos’ development ability
↓ Oocyte aging
↓ ROS level
↑ SIRT1
↑ FOXO3a
↑ SOD2
↓ BAX
[53]
Adding the inhibitor inauhzin↓ Cumulus cell expansion, cleavage and blastocyst rates-
miRNAmiR-342-3pYak
oocyte
MiR-342-3p inhibitor↓ Oocyte meiotic maturationMiR-342-3p inhibitor up-regulated DNMT1 expression[60]
↑: increases. ↓: decreases.
Table 2. Effects of endogenous factors on in vitro maturation and development of yak oocytes.
Table 2. Effects of endogenous factors on in vitro maturation and development of yak oocytes.
Exogenous FactorSampleTreatmentEffectPossible MechanismReference
Growth factorEGFYak COCsAdding 100 ng/mL EGF↑ Maturation rate
↑ Cleavage and blastocyst rates
↓ BAX
↑ BI-1
[73]
Yak COCsAdding 40 μg/mL EGF↑ Maturation rate
↑ PA embryos’ development ability
-[72]
IGF-1Yak oocyteAdding 100 ng/mL IGF-1↑ Maturation rate
↑ Cleavage and blastocyst rates
↑ CIRP[76]
FGF10Yak COCsAdding 5 ng/mL FGF10↑ Maturation rate
↑ Fertilization ability
↑ CD9
↑ CD81
↑ DNMT1
↑ DNMT3B
[6]
LIFYak oocyteAdding 50 ng/mL LIF↑ Maturation rate
↓ ROS generation
↓ Apoptosis levels
↑ Blastocyst total cell numbers
↓ Blastocyst apoptosis rate
↑ BCL2
↑ CAPASE3
↑ SURVIVIN
↑ SOD2
↑ GPX4
[84]
AntioxidantsMelatoninYak COCsAdding 10−9 M melatonin↑ Maturation rate
↑ Cleavage and blastocyst rates
↑ GSH content
↓ ROS levels
↓ Mitochondrial proteins and DNA damage extent
↓ oocyte and blastocyst apoptosis
-[98,99,100]
Vitamin CYak COCsAdding 50 μg/mL AA to IVM medium exposed to AFB1↓ ROS level
↓ Early oocyte apoptosis
↑ Mitochondrial distribution status
↑ DNA methylation
Restored actin distribution
↑ DNMT3a
↑ TET3
↑ NANOG
↑ POU5F1
↑ CDX2
↓ DNMT1
[38,100]
Vitamin AYak oocyteAdding 2 μM vitamin A↑ Maturation rate
↑ PA embryo cleavage rate
↑ STRA8
↑ RARA
↑ RXRA
[93,94]
ResveratrolYak COCs-↓ ROS levels
↑ GSH content
-[100]
CysteamineYak COCs-↑ GSH content-[100]
MicroelementZincYak COCsAdding 2 mg/L zinc sulfate↑ GSH content
↑ SOD activity
↑ Cleavage and blastocyst rates
↓ ROS levels
↑ ZnT3
↑ Zrt
↑ ZiP14
↑ SLC30A3
↑ SLC30A6
↑ SCL30A9
↑ SLC39A6
↑ SLC39A14
[103,104]
Adding 0.8 mg/L Zinc sulfate-↑ SOD1
↑ CAT
↑ TXN1
↑ PRD1
↑ PTX3
↑ TSG6
[105]
CalciumYak oocyteAdding 0.24 mM Ca2+↑ Maturation rate
↑ GSH content
↓ ROS levels
↑ activity of CaMKⅡ
↑ BCL-2
↑ EGF
↑ EGFR
↑ C-FOS
↓ BAX
[107]
SeleniumYak COCsAdding 2 μg/mL sodium selenite↑ GSH-Px activity
↑ Blastocysts rate
↑ GPX4
↑ SEPP1
↑ RPL22
↑ CCND1
[111]
Small molecule compoundsRoscovitineYak COCsPre-IVM yak COCs with 12.5 μM roscovitine for 6 h↑ CEI of COCs
↑ Uniform distribution of mitochondria
↑ TZPs
↓ ROS levels
↑ SOD2
↑ BCL-
↑ GDF9
↑ EGFR
↑ ZAR1 e
↓ BAX
[121]
CNPYak oocytePre-IVM yak oocytes with 100 nM CNP for 6 h and IVM for 28 h↑ TZPs
↑ GSH content
↓ ROS levels
↑ NPR2
↑ BCL-2
↑ GDF9
↑ EGF
↑ EGFR
↑ DNMT1
↓ BAX
[123]
GlucoseYak oocyteAdding 10 mmol/L glucose↑ Maturation rate
↑ Cleavage rate
-[131]
SucroseYak oocyteAdding 10 mmol/L sucrose↑ Nucleus maturation rate-[131]
HormoneFSHYak oocyteAdding 5 μg/mL FSH↑ Maturation rate
↑ IVF embryos’ development ability
↓ Oocyte apoptosis
↑ EFG
↑ EGFR
↑ BCL-2
↓ BAX
[132,133]
LHYak oocyteAdding 50 IU/mL LH↑ IVF embryos’ development ability-[132]
RFRP-3Yak COCsAdding 10−6 mol/L RFRP-3↑ Oocyte proliferation
↑ Oocyte apoptosis
↓ E2 and P4 concentrations
↑ CASPASE
↑ BAX
↓ LHR
↓ StAR
↓ 3b-HSD
[143]
E2Yak COCsAdding 10−4 mM endogenous 17β-estradiol↑ Cumulus expansion
↑ Cleavage and blastocyst rates
↑ HAS2
↑ PTGS2
↑ PTX3
↑ GDF9
↑ FGF10
↑ BMP15
[140]
CYP19A1Yak COCsAdding CYP19A1 inducer (AFB1)↑ E2 level
↑ Autophagy level
↑ Maturation rate
↑ Cleavage rate
↑ CYP19A1
↑ ATG5
↑ BECLIN1
↑ LC3
[144,145]
Adding CYP19A1 inhibitor (BPA)↓ E2 level
↓ Autophagy level
↓ CYP19A1
↓ ATG5
↓ BECLIN1
↓ LC3
PAF-Yak COCsAdding 10−7 mol/L PFA↑ Maturation rate
↑ Cleavage and blastocyst rates
↓ Apoptosis level
↑ BCL-2
↑ EGF
↑ EGFR
↑ C-FOS
↑ OCT-4
↑ NANOG
↓ BAX
[148,149]
↑: increases. ↓: decreases.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mo, L.; Ma, J.; Xiong, Y.; Xiong, X.; Lan, D.; Li, J.; Yin, S. Factors Influencing the Maturation and Developmental Competence of Yak (Bos grunniens) Oocytes In Vitro. Genes 2023, 14, 1882. https://doi.org/10.3390/genes14101882

AMA Style

Mo L, Ma J, Xiong Y, Xiong X, Lan D, Li J, Yin S. Factors Influencing the Maturation and Developmental Competence of Yak (Bos grunniens) Oocytes In Vitro. Genes. 2023; 14(10):1882. https://doi.org/10.3390/genes14101882

Chicago/Turabian Style

Mo, Luoyu, Jun Ma, Yan Xiong, Xianrong Xiong, Daoliang Lan, Jian Li, and Shi Yin. 2023. "Factors Influencing the Maturation and Developmental Competence of Yak (Bos grunniens) Oocytes In Vitro" Genes 14, no. 10: 1882. https://doi.org/10.3390/genes14101882

APA Style

Mo, L., Ma, J., Xiong, Y., Xiong, X., Lan, D., Li, J., & Yin, S. (2023). Factors Influencing the Maturation and Developmental Competence of Yak (Bos grunniens) Oocytes In Vitro. Genes, 14(10), 1882. https://doi.org/10.3390/genes14101882

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop